Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine opioid-free anesthesia for prevention of postoperative nausea and vomiting in non-cardiac thoracic and abdominal surgery
ChiCTR2300077224Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Incidence and severity of postoperative nausea and vomiting. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300077224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077224.